Eaton Vance Management Purchases New Stake in Medidata Solutions (MDSO)

Eaton Vance Management purchased a new position in shares of Medidata Solutions (NASDAQ:MDSO) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 82,720 shares of the company’s stock, valued at approximately $5,196,000. Eaton Vance Management owned approximately 0.14% of Medidata Solutions at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of MDSO. Dimensional Fund Advisors LP grew its position in Medidata Solutions by 40.9% during the third quarter. Dimensional Fund Advisors LP now owns 93,853 shares of the company’s stock worth $7,327,000 after buying an additional 27,264 shares in the last quarter. Schwab Charles Investment Management Inc. grew its position in Medidata Solutions by 6.3% during the fourth quarter. Schwab Charles Investment Management Inc. now owns 347,388 shares of the company’s stock worth $22,014,000 after buying an additional 20,438 shares in the last quarter. Frontier Capital Management Co. LLC grew its position in Medidata Solutions by 12.0% during the fourth quarter. Frontier Capital Management Co. LLC now owns 54,912 shares of the company’s stock worth $3,480,000 after buying an additional 5,863 shares in the last quarter. Conestoga Capital Advisors LLC grew its position in Medidata Solutions by 10.9% during the fourth quarter. Conestoga Capital Advisors LLC now owns 735,957 shares of the company’s stock worth $46,638,000 after buying an additional 72,195 shares in the last quarter. Finally, Strs Ohio grew its position in Medidata Solutions by 13.9% during the fourth quarter. Strs Ohio now owns 163,797 shares of the company’s stock worth $10,379,000 after buying an additional 20,000 shares in the last quarter.

In other Medidata Solutions news, CFO Rouven Bergmann sold 2,000 shares of the firm’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $67.47, for a total value of $134,940.00. Following the sale, the chief financial officer now owns 82,775 shares of the company’s stock, valued at approximately $5,584,829.25. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Tarek Sherif sold 26,836 shares of the firm’s stock in a transaction on Monday, March 12th. The shares were sold at an average price of $70.25, for a total value of $1,885,229.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 45,231 shares of company stock worth $3,166,939. Company insiders own 4.70% of the company’s stock.

A number of brokerages recently issued reports on MDSO. Royal Bank of Canada set a $82.00 price target on Medidata Solutions and gave the stock a “hold” rating in a research report on Thursday, February 8th. TheStreet raised Medidata Solutions from a “c+” rating to a “b-” rating in a research report on Monday, March 12th. Dougherty & Co reissued a “buy” rating and set a $89.00 price target (up previously from $79.00) on shares of Medidata Solutions in a research report on Thursday, May 10th. ValuEngine raised Medidata Solutions from a “sell” rating to a “hold” rating in a research report on Thursday, April 12th. Finally, BidaskClub raised Medidata Solutions from a “hold” rating to a “buy” rating in a research report on Friday, May 4th. Four investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $83.71.

Shares of MDSO stock opened at $77.54 on Friday. The firm has a market capitalization of $4.59 billion, a price-to-earnings ratio of 85.21, a price-to-earnings-growth ratio of 3.89 and a beta of 1.49. Medidata Solutions has a fifty-two week low of $59.60 and a fifty-two week high of $85.92. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.63 and a current ratio of 1.63.

Medidata Solutions (NASDAQ:MDSO) last issued its earnings results on Thursday, April 19th. The company reported $0.40 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.35 by $0.05. The firm had revenue of $149.20 million for the quarter, compared to the consensus estimate of $146.73 million. Medidata Solutions had a return on equity of 11.36% and a net margin of 7.96%. The company’s revenue was up 16.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.31 EPS. analysts forecast that Medidata Solutions will post 0.98 earnings per share for the current year.

About Medidata Solutions

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.

Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions (NASDAQ:MDSO).

Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply